We describe the pathophysiology, prevention and treatment strategies emphasising the use of hyaluronidase in the management of mannitol extravasation induced compartment syndrome
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Mannitol is one of the indispensable drugs in neurosurgery to manage the raised intracranial pressure.
📊
Key Findings & Data:We report a case of a 50-year-old female who developed forearm compartment syndrome due to mannitol extravasation after undergoing surgery for frontal glioma under general anaesthesia.
💡
Conclusion & Impact:We describe the pathophysiology, prevention and treatment strategies emphasising the use of hyaluronidase in the management of mannitol extravasation induced compartment syndrome
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Mannitol is one of the indispensable drugs in neurosurgery to manage the raised intracranial pressure. Though considered safe, extravasation of mannitol into the tissues can cause considerable morbidity with the consequent development of compartment syndrome. We report a case of a 50-year-old female who developed forearm compartment syndrome due to mannitol extravasation after undergoing surgery for frontal glioma under general anaesthesia. The severe forearm compartment syndrome could be successfully managed without fasciotomy using hyaluronidase. We describe the pathophysiology, prevention and treatment strategies emphasising the use of hyaluronidase in the management of mannitol extravasation induced compartment syndrome
🔖
Cite This Article
KAUR, M., BALAKRİSHNAN, N., GOSAL, J. S., BHATİA, P., BHASKAR, S., JHA, D. K. (2021). Efficacy of Hyaluronidase in the Mannitol Extravasation Induced Compartment Syndrome-A Case Report and Review of LiteratureManbi. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 49 - Sayı: 4, 329–333. https://ajindex.com/articles/370418
Stahl S, Lerner A. Compartment syndrome of the forearm fol- lowing extravasation of mannitol in an unconscious patient. Acta Neurochir (Wien). 2000;142(8):945-946. [CrossRef], 2. Edwards JJ, Samuels D, Fu ES. Forearm compartment syn- drome from intravenous mannitol extravasation during general anesthesia. Anesth Analg. 2003;96(1):245-246. 3. Kumar MM, Sprung J. The use of hyaluronidase to treat man- nitol extravasation. Anesth Analg. 2003;97(4):1199-1200. [CrossRef] 4. Eroglu A, Uzunlar H. Forearm compartment syndrome after intravenous mannitol extravasation in a carbosulfan poi- soning patient. J Toxicol Clin Toxicol. 2004;42(5):649-652. [CrossRef] 5. Erickson BA, Yap RL, Pazona JF, Hartigan BJ, Smith ND. Mannitol extravasation during partial nephrectomy leading to forearm compartment syndrome. Int Braz J Urol. 2007;33(1):68-71. [CrossRef] 6. Rose RE, Felix R, Crawford-Sykes A, Venugopal R, Wharfe G, Arscott G. Extravasation injuries. West Indian Med J. 2008;57:40-47. 7. O’Reilly C, McKay FM, Duffty P, Lloyd DJ. Glyceryl trini- trate in skin necrosis caused by extravasation of parenteral nutrition. Lancet. 1988;332(8610):565-566. [CrossRef] 8. Brown AS, Hoelzer DJ, Piercy SA. Skin necrosis from extrava- sation of intravenous fluids in children. Plast Reconstr Surg. 1979;64(2):145-150. [CrossRef] 9. Shawkat H, Westwood MM, Mortimer A. Mannitol: A review of its clinical uses. Contin Educ Anaesth Crit Care Pain. 2012;12:82- 85. [CrossRef] 10. Lawson SL, Brady W, Mahmoud A. Identification of highly concentrated dextrose solution (50% dextrose) extravasation and treatment—A clinical report. Am J Emerg Med. 2013;31(5):886.e3-e5. [CrossRef] 11. Bhaskar S, Gosal JS, Garg M, Jha DK. Letter: The neurologi- cal examination. Oper Neurosurg (Hagerstown). 2020; pii: Opaa047. [CrossRef] 12. Buhren BA, Schrumpf H, Hoff NP, Bo ̈lke E, Hilton S, Gerber PA. Hyaluronidase: From clinical applications to molecular and cellular mechanisms. Eur J Med Res. 2016;21:5. [CrossRef] 13. Maly C, Fan KL, Rogers GF, et al. A primer on the acute man- agement of intravenous extravasation injuries for the plastic sur- geon. Plast Reconstr Surg Glob Open. 2018;6(4):e1743. [CrossRef] 14. Bertelli G. Prevention and management of extravasation of cytotoxic drugs. Drug Saf. 1995;12:245-255. [CrossRe